TEVA has been in the news 563% more than usual
May 28, 2025, 12:32 PM
-6.38%
What does TEVA do
It seems there is no content provided to summarize. Please share the text you'd like summarized, and I'll be happy to help!
TEVA has been in the news recently: Teva Pharmaceutical Industries Ltd has initiated IND-enabling studies in collaboration with Biolojic Design Ltd for BD9, a multibody therapy targeting TSLP and IL-13. Truist Securities has assigned Teva a buy rating with a price target of $25 per share, suggesting a potential 41% increase despite a 20% decline in its stock this year.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.